• About CCSB
  • |
  • News
  • |
  • Contact Us
  • |
  • Site Map
  •  
  •   中文版
CCSB's
  • ESG
  • Investor Relations
  • Events
  • Contract Research
  • Contract Manufacturing
  • API Products
CCBS NEWS

CCBS NEWS

News
Download
Contact Us
search

News

Home > News > News
news title
  • 2026/03/03Cenra API Solutions and BioDuro Form JV to Strengthen API Manufacturing
  • 2026/02/24CCSB obtained US. patent: Crystal Form A、B、C、D、E、F and G of Selumetinib Sulfate.
  • 2026/01/30CCSB/CAS obtained US patent: Preparation Method of Setmelanotide
  • 2025/12/29Obtained Taiwan Patent: Crystal Form A、B、C、D、E、F and G of Selumetinib Sulfate
  • 2025/11/12 2025 Corporate Sustainability Report Award
  • 2025/09/10The company accomplished Ethyl Icosapentate, Everolimus audit
  • 2025/09/04The company accomplished Everolimus audit
  • 2025/08/14The company accomplished Sugammadex Sodium audit
  • 2025/06/05The company accomplished Everolimus audit
  • 2025/05/29The company accomplished Tacrolimus audit, a client from India
   1  2  3  4  5  6  7  8  9  10 Next  
© Chunghwa Chemical Synthesis & Biotech Co. Ltd. All right reserved.